» Articles » PMID: 34318859

Recent Advances in the Synthesis and Applications of Graphene-polypeptide Nanocomposites

Overview
Journal J Mater Chem B
Date 2021 Jul 28
PMID 34318859
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The combination of peptides and graphene-derived materials provides a new way to prepare graphene-based nanocomposites with unique structures, properties, and functions. The modification of graphene with different polypeptides not only improves the biocompatibility and biological recognition ability of graphene-based materials, but also greatly expands their application fields. In this work, we summarize different interactions between graphene and polypeptides, and the synthesis methods of novel functional graphene-polypeptide nanocomposites based on the interactions in recent years (from 2016 to present). In addition, the potential applications of graphene-peptide hybrid nanocomposites in biomedicine, tissue engineering, biosensors, environmental science engineering, optoelectronic materials, and energy storage are introduced. We hope that this review will help readers to understand the methods and mechanisms of the modification of graphene surfaces with biomolecules, and promote readers to understand the synthesis and applications of graphene-based nanocomposites. This work may provide hints and references for the development of peptide sequence design, and biomedical and functional materials, and will help in designing and synthesizing novel graphene-based nanomaterials with unique properties and suitable for various applications in the future.

Citing Articles

Innovative approaches in lung tissue engineering: the role of exosome-loaded bioscaffolds in regenerative medicine.

Torkashvand M, Rezakhani L, Habibi Z, Mikaeili A, Rahmati S Front Bioeng Biotechnol. 2025; 12:1502155.

PMID: 39758953 PMC: 11695380. DOI: 10.3389/fbioe.2024.1502155.


Fluorescence immunosensor based on functional nanomaterials and its application in tumor biomarker detection.

Huang J, Wei F, Cui Y, Hou L, Lin T RSC Adv. 2022; 12(48):31369-31379.

PMID: 36349017 PMC: 9624183. DOI: 10.1039/d2ra04989a.


Hybrid laser activated phycocyanin/capecitabine treatment of cancerous MCF7 cells.

Jahdi Abdollahi S, Parvin P, Mayahi S, Seyedi S, Mohsenian P, Ramezani F Biomed Opt Express. 2022; 13(7):3939-3953.

PMID: 35991918 PMC: 9352291. DOI: 10.1364/BOE.459737.